Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.56
Bid: 4.22
Ask: 4.80
Change: 0.15 (3.40%)
Spread: 0.58 (13.744%)
Open: 4.16
High: 4.56
Low: 4.16
Prev. Close: 4.41
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of PHC Reclamation Inc.

28 May 2010 07:00

RNS Number : 6925M
Plant Health Care PLC
28 May 2010
 



28 May 2010

 

   

 

Plant Health Care plc

("Plant Health Care" or "the Company")

 

SALE OF PHC RECLAMATION, INC.

-Sale of non core business-

 

Plant Health Care (AIM: PHC.L), a leading provider of natural products to the agriculture and landscaping industries, announces that it has completed the sale of its wholly-owned subsidiary PHC Reclamation, Inc. ("PHC REC") to RE/SPEC, Inc. for a total, maximum consideration of $0.385 million to be satisfied in cash. $0.225 million is payable on completion with the balance of $0.160 million payable over a twelve month period. An interest rate of 7 per cent per annum will apply to the balance.

 

For the year ended 31 December 2009, PHC REC, Inc. made a revenue contribution to the Company of $1.3 million and a $0.111 million contribution to operating profit. As a result of this sale, PHC REC will make a contribution to revenue and profits for approximately four months of the 2010 financial year.

 

Under the terms of the sale agreement, all eleven PHC REC staff, together with net assets totaling $.235 million will be transferred to the new owners.

 

Commenting on the sale, John Brady CEO of Plant Health Care said, "Over recent years, our focus has shifted away from the reclamation industry and towards agriculture where there are very substantial commercialisation opportunities for our key technologies, Harpin and Myconate. By unlocking the value in PHC REC we have realised equity which can be reinvested in our core activities and ensured that our efforts are concentrated on our opportunities within agriculture and landscaping."

 

 

-Ends-

 

 

For further information please visit www.planthealthcare.com or contact:

 

John Brady

Evolution Securities Limited

Tavistock Communications

Chief Executive

Tim Worlledge/Tim Redfern

Jeremy Carey/Matt Ridsdale

Tel: +1 603 525 3702

Tel: +44 (0) 20 7071 4300

Tel: +44 (0) 20 7920 3150

 

 

Notes to Editors:

 

About Plant Health Care

 

About Plant Health Care plc: Plant Health Care plc ("PHC") is a leading provider of naturally derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately [90] employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") in February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.

 

About PHC REC

 

PHC REC specialises in mining, environmental and reclamation consulting services. It provides biological and engineering based solutions for land reclamation and revegetation projects. As a leader in the use of mycorrhizal fungi, PHC REC utilises its expertise for the successful establishment of vegetation on lands distressed by earthwork activities, such as mining and construction work, and by natural processes, such as extreme climatic and geographic location conditions found in arid and semi-arid regions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISDDLFLBEFXBBZ
Date   Source Headline
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.